Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer (original) (raw)

• Arking DE, Becker DM, Yanek LR, Fallin D, Judge DP, Moy TF et al. (2003). KLOTHO allele status and the risk of early-onset occult coronary artery disease. Am J Hum Genet 72: 1154–1161.
  Article CAS Google Scholar
• Arking DE, Krebsova A, Macek Sr M, Macek Jr M, Arking A, Mian IS et al. (2002). Association of human aging with a functional variant of klotho. Proc Natl Acad Sci 99: 856–861.
  Article CAS Google Scholar
• Bartucci M, Morelli C, Mauro L, Ando S, Surmacz E . (2001). Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Cancer Res 61: 6747–6754.
  CAS PubMed Google Scholar
• Cha S-K, Ortega B, Kurosu H, Rosenblatt KP, Kuro-o M, Huang C-L . (2008). Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1. Proc Natl Acad Sci 105: 9805–9810.
  Article CAS Google Scholar
• Chang Q, Hoefs S, van der Kemp AW, Topala CN, Bindels RJ, Hoenderop JG . (2005). The {beta}-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science 310: 490–493.
  Article CAS Google Scholar
• Chen C-D, Podvin S, Gillespie E, Leeman SE, Abraham CR . (2007). Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proc Natl Acad Sci 104: 19796–19801.
  Article CAS Google Scholar
• Chihara Y, Rakugi H, Ishikawa K, Ikushima M, Maekawa Y, Ohta J et al. (2006). Klotho protein promotes adipocyte differentiation. Endocrinology 147: 3835–3842.
  Article CAS Google Scholar
• de Oliveira RM . (2006). Klotho RNAi induces premature senescence of human cells via a p53/p21 dependent pathway. FEBS Letters 580: 5753–5758.
  Article Google Scholar
• den Dekker E, Hoenderop JGJ, Nilius B, Bindels RJM . (2003). The epithelial calcium channels, TRPV5 & TRPV6: from identification towards regulation. Cell Calcium 33: 497–507.
  Article CAS Google Scholar
• Fenig E, Szyper-Kravitz M, Yerushalmi R, Lahav M, Beery E, Wasserman L et al. (2002). Basic fibroblast growth factor mediated growth inhibition in breast cancer cells is independent of ras signaling pathway. Oncol Rep 9: 875–877.
  CAS PubMed Google Scholar
• Fenig E, Wieder R, Paglin S, Wang H, Persaud R, Haimovitz-Friedman A et al. (1997). Basic fibroblast growth factor confers growth inhibition and mitogen-activated protein kinase activation in human breast cancer cells. Clin Cancer Res 3: 135–142.
  CAS PubMed Google Scholar
• Geier A, Beery R, Haimsohn M, Karasik A . (1995). Insulin-like growth factor-1 inhibits cell death induced by anticancer drugs in the MCF-7 cells: involvement of growth factors in drug resistance. Cancer Invest 13: 480–486.
  Article CAS Google Scholar
• Gery S, Tanosaki S, Bose S, Bose N, Vadgama J, Koeffler HP . (2005). Down-regulation and growth inhibitory role of C/EBP{alpha} in breast cancer. Clin Cancer Res 11: 3184–3190.
  Article CAS Google Scholar
• Gomis RR, Alarcon C, Nadal C, Van Poznak C, Massague J . (2006). C/EBP[beta] at the core of the TGF[beta] cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell 10: 203–214.
  Article CAS Google Scholar
• Haimsohn M, Beery R, Karasik A, Kanety H, Geier A . (2002). Aurintricarboxylic acid induces a distinct activation of the IGF-I receptor signaling within MDA-231 cells. Endocrinology 143: 837–845.
  Article CAS Google Scholar
• Haluska P, Carboni JM, Loegering DA, Lee FY, Wittman M, Saulnier MG et al. (2006). In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417. Cancer Res 66: 362–371.
  Article CAS Google Scholar
• Hsiung R, Zhu W, Klein G, Qin W, Rosenberg A, Park P et al. (2002). High basic fibroblast growth factor levels in nipple aspirate fluid are correlated with breast cancer. Cancer J 8: 303–310.
  Article Google Scholar
• Ikushima M, Rakugi H, Ishikawa K, Maekawa Y, Yamamoto K, Ohta J et al. (2006). Anti-apoptotic and anti-senescence effects of Klotho on vascular endothelial cells. Biochem Biophys Res Commun 339: 827–832.
  Article CAS Google Scholar
• Imura A, Iwano A, Tohyama O, Tsuji Y, Nozaki K, Hashimoto N et al. (2004). Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane. FEBS Lett 565: 143–147.
  Article CAS Google Scholar
• Imura A, Tsuji Y, Murata M, Maeda R, Kubota K, Iwano A et al. (2007). {alpha}-klotho as a regulator of calcium homeostasis. Science 316: 1615–1618.
  Article CAS Google Scholar
• Ito S, Kinoshita S, Shiraishi N, Nakagawa S, Sekine S, Fujimori T et al. (2000). Molecular cloning and expression analyses of mouse [beta]klotho, which encodes a novel Klotho family protein. Mech Dev 98: 115–119.
  Article CAS Google Scholar
• Kato Y, Arakawa E, Kinoshita S, Shirai A, Furuya A, Yamano K et al. (2000). Establishment of the anti-klotho monoclonal antibodies and detection of klotho protein in kidneys. Biochem Biophys Res Commun 267: 597–602.
  Article CAS Google Scholar
• Kim Y, Kim J-H, Nam YJ, Kong M, Kim YJ, Yu K-H et al. (2006). Klotho is a genetic risk factor for ischemic stroke caused by cardioembolism in Korean females. Neurosci Lett 407: 189–194.
  Article CAS Google Scholar
• Korah RM, Sysounthone V, Golowa Y, Wieder R . (2000). Basic fibroblast growth factor confers a less malignant phenotype in MDA-MB-231 human breast cancer cells. Cancer Res 60: 733–740.
  CAS PubMed Google Scholar
• Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T et al. (1997). Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390: 45–51.
  Article CAS Google Scholar
• Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt KP et al. (2006). Regulation of fibroblast growth factor-23 signaling by Klotho. J Biol Chem 281: 6120–6123.
  Article CAS Google Scholar
• Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P et al. (2005). Suppression of aging in mice by the hormone Klotho. Science 309: 1829–1833.
  Article CAS Google Scholar
• Lacroix M, Leclercq G . (2004). Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treatment 83: 249–289.
  Article CAS Google Scholar
• Li X, Kim JW, Gronborg M, Urlaub H, Lane MD, Tang Q-Q . (2007). Role of cdk2 in the sequential phosphorylation/activation of C/EBPbeta during adipocyte differentiation. Proc Natl Acad Sci 104: 11597–11602.
  Article CAS Google Scholar
• Matsumura Y, Aizawa H, Shiraki-Iida T, Nagai R, Kuro-o M, Nabeshima Y . (1998). Identification of the human Klotho gene and its two transcripts encoding membrane and secreted Klotho protein. Biochem Biophys Res Commun 242: 626–630.
  Article CAS Google Scholar
• Mitsiades CS, Mitsiades NS, McMullan CJ, Poulaki V, Shringarpure R, Akiyama M et al. (2004). Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors. Cancer Cell 5: 221–230.
  Article CAS Google Scholar
• Ohyama Y, Kurabayashi M, Masuda H, Nakamura T, Aihara Y, Kaname T et al. (1998). Molecular cloning of rat klotho cDNA: markedly decreased expression of klotho by acute inflammatory stress. Biochem Biophys Res Commun 251: 920–925.
  Article CAS Google Scholar
• Shiraki-Iida T, Aizawa H, Matsumura Y, Sekine S, Iida A, Anazawa H et al. (1998). Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein. FEBS Lett 424: 6–10.
  Article CAS Google Scholar
• Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K et al. (2006). Klotho converts canonical FGF receptor into a specific receptor for FGF23. Science 444: 770–774.
  CAS Google Scholar
• Utsugi T, Ohno T, Ohyama Y, Uchiyama T, Saito Y, Matsumura Y et al. (2000). Decreased insulin production and increased insulin sensitivity in the klotho mutant mouse, a novel animal model for human aging. Metabolism 49: 1118–1123.
  Article CAS Google Scholar
• Vandermoere F, El Yazidi-Belkoura I, Adriaenssens E, Lemoine J, Hondermarck H . (2005). The antiapoptotic effect of fibroblast growth factor-2 is mediated through nuclear factor-[kappa]B activation induced via interaction between Akt and I[kappa]B kinase-[beta] in breast cancer cells. Oncogene 24: 5482–5491.
  Article CAS Google Scholar
• Wolf I, Bose S, Williamson EA, Miller CW, Karlan BY, Koeffler HP . (2007). FOXA1: Growth inhibitor and a favorable prognostic factor in human breast cancer. Int J Cancer 120: 1013–1022.
  Article CAS Google Scholar
• Wolf I, O'Kelly J, Rubinek T, Tong M, Nguyen A, Lin BT et al. (2006a). 15-Hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer. Cancer Res 66: 7818–7823.
  Article CAS Google Scholar
• Wolf I, Sadetzki S, Gluck I, Oberman B, Ben-David M, Papa MZ et al. (2006b). Association between diabetes mellitus and adverse characteristics of breast cancer at presentation. Eur J Cancer 42: 1077–1082.
  Article Google Scholar
• Yee D . (2006). Targeting insulin-like growth factor pathways. Br J Cancer 94: 465–468.
  Article CAS Google Scholar
• Zarrabeitia M, Hernández JL, Valero C, Zarrabeitia A, Ortiz F, Gonzalez-Macias J et al. (2007). Klotho gene polymorphism and male bone mass. Calcif Tissue Int 80: 10–14.
  Article CAS Google Scholar